Pulmonx, a company in the Zacks Medical Info Systems industry, underperformed the S&P 500 market so far.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pulmonx, a company in the Zacks Medical Info Systems industry, underperformed the S&P 500 market so far.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pulmonx (United States)
company in Redwood City, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksPulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.4.